Analystreport

Vertex Pharmaceuticals (NASDAQ:VRTX) is now covered by analysts at Scotiabank. They set a "sector outperform" rating and a $495.00 price target on the stock.

Vertex Pharmaceuticals Incorporated  (VRTX) 
Last vertex pharmaceuticals incorporated earnings: 4/29 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.vrtx.com